Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2000
10/05/2000CA2368484A1 Substrates for thioredoxin reductase
10/05/2000CA2368465A1 Avermectin derivatives
10/05/2000CA2368463A1 Phosphate containing macrocyclic immunomodulators
10/05/2000CA2368460A1 Derivatives of pyrimido¬6,1-a|isoquinolin-4-one
10/05/2000CA2368455A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368233A1 Recombinant neospora antigens and their uses
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2368014A1 Casb619 involved in colon cancers
10/05/2000CA2367995A1 Novel formulations comprising lipid-regulating agents
10/05/2000CA2367792A1 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2366012A1 Methods of treating leukemia
10/05/2000CA2365995A1 Cyclic glycerophosphates and analogs thereof
10/05/2000CA2365401A1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
10/05/2000CA2365297A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/05/2000CA2365128A1 Novel formulations comprising lipid-regulating agents
10/05/2000CA2365122A1 Peroxovanadium compounds as antineoplastic agents for the treatment of cancer
10/05/2000CA2364622A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000CA2362409A1 Sulfamate containing macrocyclic immunomodulators
10/05/2000CA2362388A1 Dermatological topical composition
10/05/2000CA2361366A1 Novel compounds
10/05/2000CA2361016A1 Diaryl derivatives and their use as medicaments
10/05/2000CA2359652A1 Novel prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of peripheral vascular disease and pulmonaryhypertension
10/05/2000CA2329261A1 Susceptibility to psoriasis
10/05/2000CA2323140A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same
10/05/2000CA2291286A1 Chitosan-containing soft capsule and process for producing the same
10/04/2000EP1041152A1 Retroviral vectors
10/04/2000EP1041144A1 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/04/2000EP1041083A1 Modified timp
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041068A1 Compounds for treating and preventing diabetic complications
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators
10/04/2000EP1040838A1 Stable aqueous EM 12 solution
10/04/2000EP1040837A2 Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder
10/04/2000EP1040833A1 Bone resorption suppressing agent
10/04/2000EP1040832A1 Creams containing vitamin d 3? derivatives
10/04/2000EP1040831A2 Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
10/04/2000EP1040830A1 Remedy for neurodegenerative diseases
10/04/2000EP1040829A2 Prokinetic agents for treating gastric hypomotility and related disorders
10/04/2000EP1040828A1 Water-base liquid preparation
10/04/2000EP1040827A2 Use of 2-alkylpyrrolidines for the treatment of diabetes
10/04/2000EP1040826A1 Medicinal use of cromoglycic acid compounds
10/04/2000EP1040825A1 Means for diagnosing bladder carcinoma
10/04/2000EP1040757A1 Antiseptic/antifungal agent and endermic liniment composition which contains it
10/04/2000EP1040190A1 Serine proteinase inhibitors
10/04/2000EP1040185A2 Neural precursor cells, method for the production and use thereof in neural defect therapy
10/04/2000EP1040183A1 Nucleic acid encoding mammalian ubr1
10/04/2000EP1040125A1 Glucose regulated gene
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1040110A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione,maleic acid salt,hydrate as pharmaceutical
10/04/2000EP1040109A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
10/04/2000EP1040108A1 Ortho-anthranilamide derivatives as anti-coagulants
10/04/2000EP1040107A1 6-o-alkyl derivatives of erythronolide b
10/04/2000EP1040106A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/04/2000EP1040102A1 Arylthiazolidinedione derivatives
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1040097A1 Potassium channel openers
10/04/2000EP1040096A1 Neuroprotective agents
10/04/2000EP1040095A1 Cyclohexene carboxylates as neuraminidase inhibitors
10/04/2000EP1040094A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
10/04/2000EP1039937A2 Novel sterilization process for pharmaceutical suspensions
10/04/2000EP1039935A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
10/04/2000EP1039933A2 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS
10/04/2000EP1039932A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
10/04/2000EP1039919A1 Composition for improving mental capabilities in mammals
10/04/2000EP1039917A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract
10/04/2000EP1039916A2 Use of fucane for regulating the reconstruction of connective tissues
10/04/2000EP1039915A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
10/04/2000EP1039914A1 Cyclooxygenase-2 inhibition
10/04/2000EP1039913A1 Progesterone tablet and preparation method
10/04/2000EP1039912A1 Angiostatic agents and compositions for controlling ocular hypertension
10/04/2000EP1039911A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS
10/04/2000EP1039910A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
10/04/2000EP1039909A1 Method and composition of an oral preparation of itraconazole
10/04/2000EP1039908A1 Molecular dispersion composition with enhanced bioavailability
10/04/2000EP1039907A1 Thrombin inhibitors
10/04/2000EP1039906A1 Novel metal complexes
10/04/2000EP1039905A1 Pharmaceutical formulation comprising glycine as a stabilizer
10/04/2000EP1039904A1 Synergistic antimicrobial compositions
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039902A2 Inhibitors of gap junction communication
10/04/2000EP1039901A1 Treatment for alzheimer's disease
10/04/2000EP1039900A2 Pharmaceutical composition containing sibutramine and orlistat
10/04/2000EP1039899A2 Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative
10/04/2000EP1039898A1 Compositions comprising cannabinoids
10/04/2000EP1039896A1 Method and composition for delivering zinc to the nasal membrane
10/04/2000EP1039895A1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma
10/04/2000EP1039894A1 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039892A2 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
10/04/2000EP1039891A1 Treatment of scar tissue using lipoic acid
10/04/2000EP1039890A1 Novel salts of metformin and method
1 ... 6234 6235 6236 6237 6238 6239 6240 6241 6242 6243 6244 6245 6246 6247 6248 6249 6250 6251 6252 6253 6254 ... 7860